Stock Information
Oruka Therapeutics Inc (ORKA)
Ticker Symbol: ORKA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,580.70 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.3166
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -25.3%
Latest News
-
Guggenheim Reiterates Buy on Oruka Therapeutics, Maintains $125 Price Target
Thu, Apr 9, 2026 9:50 AM
-
Oruka Therapeutics shares are trading higher after Barclays maintained its Overweight rating and raised its price target on the stock from $50 to $78.
Tue, Apr 7, 2026 2:48 PM
-
Barclays Maintains Overweight on Oruka Therapeutics, Raises Price Target to $78
Tue, Apr 7, 2026 2:06 PM
-
Oruka Therapeutics shares are trading higher after Guggenheim maintained a Buy rating on the stock and raised its price target from $60 to $125.
Mon, Apr 6, 2026 12:55 PM
-
Guggenheim Maintains Buy on Oruka Therapeutics, Raises Price Target to $125
Mon, Apr 6, 2026 7:24 AM
Key Financials
Financial data not available
